Saccharomyces cerevisiae as a model system to study the response to anticancer agents

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Cancer therapeutics require novel strategies beyond standard protocols.
• Yeast models, particularly Saccharomyces cerevisiae, share conserved cellular processes with humans, making them valuable for studying cancer development and drug responses.
• Despite their potential, yeast models are underutilized in cancer research and antineoplastic agent screening.

Purpose of the Study:

• To discuss and exemplify the use of Saccharomyces cerevisiae as a model system for anticancer research.
• To highlight the utility of mutant yeast panels in mimicking cancer phenotypes and studying tumor features.
• To explore the application of yeast models in screening for synthetic lethal interactions relevant to cancer.

Main Methods:

• Utilizing Saccharomyces cerevisiae as a model organism due to its conserved cellular processes and homology to human cells.
• Employing mutant yeast panels to investigate key determinants in genomic maintenance, including DNA repair, cell cycle control, and epigenetics.
• Leveraging yeast's efficiency for rapid and inexpensive compound screening.

Main Results:

• Demonstrated the potential of yeast models to mimic human cancer phenotypes.
• Showcased the application of mutant yeast panels for screening anticancer agents and identifying synthetic lethal interactions.
• Highlighted the benefits of yeast as a tool for understanding genetic contexts of drug sensitivity and resistance.

Conclusions:

• Saccharomyces cerevisiae is an underused but powerful model for anticancer research and drug discovery.
• Mutant yeast panels provide a robust platform for studying cancer biology and identifying novel therapeutic targets.
• Strategies exist to overcome the limitations of yeast models, further enhancing their utility in oncology.